Listed by the USPTO as POLAND, CHERIE MICHELLE
Tech Center 3700 • Art Units: 1647 3771 3794 3796
This examiner grants 60% of resolved cases
Cherie Michelle Poland serves in Art Unit 1647 within Tech Center 3700. She has 607 resolved cases and an allowance rate of 59.6 percent. The interview lift is 33.2 percent, indicating that interviews are effective in this examiner's practice and can increase the chances of a positive outcome. The median days to allowance is 1306, which is a consideration for medical device applicants.
Covidien L.P., Boston Scientific Corporation, and Cardiovascular Systems Inc. are top companies appearing before her. Firms like BALLARD SPAHR LLP, Kagan Binder, PLLC, and SEAGER, TUFTE & WICKHEM, LLP are prominent. The 59.6 percent allowance rate and 1306-day median pendency are balanced by the 33.2 percent interview lift. Practitioners should consider interviews a tool for success to navigate the 1306-day median pendency and improve upon the 59.6 percent baseline allowance rate.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19053129 | ASPIRATION CATHETER HAVING DISTAL SIDEWALL OPENING | Non-Final OA | Covidien LP |
| 18760279 | SURGICAL ROBOTIC SYSTEM AND METHOD FOR DEPLOYING A PROBE OF A MULTIFUNCTION SURGICAL INSTRUMENT | Non-Final OA | Covidien LP |
| 18281949 | ROBOTIC REMOTE CENTER OF MOTION WITH ACTIVE PORTAL/TROCAR MANIPULATION | Final Rejection | Covidien LP |
| 18117691 | SURGICAL END EFFECTORS | Final Rejection | Covidien LP |
| 19201511 | LEFT ATRIAL APPENDAGE IMPLANT | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 19171918 | STENT AND ASSOCIATED SYSTEMS AND METHODS | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18989240 | EMBOLIC PROTECTION DEVICES AND METHODS FOR EMBOLIC PROTECTION | Final Rejection | Boston Scientific Scimed, Inc. |
| 19202037 | SURGICAL INSTRUMENTS FOR APPLYING MULTIPLE CLIPS | Non-Final OA | INTUITIVE SURGICAL OPERATIONS, INC. |
| 17983513 | UTERINE MANIPULATOR FOR ROBOTIC SURGICAL SYSTEM | Non-Final OA | Cilag GmbH International |
| 17957923 | ADAPTING TISSUE TREATMENT MOTION PARAMETERS BASED ON SITUATIONAL PARAMETERS | Final Rejection | Cilag GmbH International |
| 18859885 | SYSTEMS AND METHODS FOR MODIFYING AN AIRWAY | Non-Final OA | The General Hospital Corporation |
| 18298490 | CONTROL COMPONENT WITH FORCE FEEDBACK | Final Rejection | ForSight Robotics Ltd. |
| 18614990 | OCCLUSION APPARATUS AND METHODS | Non-Final OA | Medtronic, Inc. |
| 18991527 | Intravascular Lithoplasty System With Improved Durability, Efficiency and Pressure Output Variability | Non-Final OA | Cardiovascular Systems, Inc. |
| 18866415 | MANAGEMENT OF STORED ANGULAR MOMENTUM IN STALLED INTRAVASCULAR ROTATIONAL DRIVE SHAFTS FOR ATHERECTOMY | Final Rejection | CARDIOVASCULAR SYSTEMS, INC. |
| 17938490 | ROTATIONAL DRIVE SHAFTS AND INTRAVASCULAR MEDICAL DEVICES THEREOF | Final Rejection | Cardiovascular Systems, Inc. |
| 17808325 | INTRA-KIDNEY STONE DISRUPTOR | Non-Final OA | GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA |
| 17846405 | SYSTEMS AND METHODS FOR TREATING THE PATENT FOREMAN OVALE AND ATRIAL SEPTAL DEFECT | Final Rejection | Ventrimend, Inc |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy59.6% of resolved applications examined by Cherie Michelle Poland were allowed (607 resolved cases), compared with 39.7% across Art Unit 1647 over the last five years.
This examiner's interview lift is +33.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Cherie Michelle Poland took 1,306 days on average from filing to allowance.
Cherie Michelle Poland examines applications in Art Unit 1647 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
